Hatchtech Pty Ltd to explore strategic alternatives for commercialization of Xeglyze™ lotion in the U.S.

chevron_leftPreviosly
OneVentures appoints new Venture Partner
07 May 2015
Nextchevron_right
Vaxxas Nanopatch on Channel 7 News and Today Tonight
23 February 2015

You may also like

24 March 2014

charmhealth names Gary Lakin as new CEO

12 January 2021

Clinical Genomics Announces Nationwide Expansion of Patient Access to COLVERA®

30 November 2020

OneVentures Growth (Equity) Fund V combines capital and executional support to tech companies

28 October 2019

Immunology Company Kira Biotech launches with $20M Series A Funding

19 May 2020

OneVentures expands team to internationalise its healthcare portfolio

02 August 2020

FDA Approves Xeglyze™ for the topical treatment of head lice infestation

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor